Oct. 25 at 1:59 AM
$SNDX Well, this didn’t go exactly according to plan. If there had been a run-up beforehand, I’d understand the sell-off after the PDUFA announcement, but without a run-up?
Nevertheless, I remain extremely confident in this company and its two drugs for the foreseeable future (at least until the combo studies arrive). Since I missed the party after the trading halt yesterday, I’m hoping to be able to add significantly to my position at the current lower price.
Goal: 16k shares, average
$11. Expect this to get to at least 2b+ market cap.
Glta.